Is Akero Therapeutics, Inc. (AKRO) a Buy, Sell, or Hold?
Akero Therapeutics, Inc.
NASDAQ:AKRO
$54.65 USD
$0 (0.0%)
- Volume
- 11.61M
- Average Volume
- 2.56M
- Market Capitalization
- $4.5B
- P/E Ratio
- -19.87
- Dividend Yield
- 0.00%
- Price Target
- $54.00
- Year High
- $58.40
- Year Low
- $21.34
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $15.83
Analyst Rating
N/A
0 Rating Score
UPSIDE/DOWNSIDE
1.2% UPSIDE
$54.00 Price Target
UPSIDE/DOWNSIDE HIGH
-2.4% DOWNSIDE
$56.00 Price Target High
UPSIDE/DOWNSIDE LOW
43.8% UPSIDE
$38.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Andrew Fein | $72 | $45.62 | 2025-09-04 06:13 AM | 57.8% |
| H.C. Wainwright | Ed Arce | $50 | $26.97 | 2024-09-17 02:50 AM | 85.4% |
| Canaccord Genuity | Edward Nash | $56 | $23.43 | 2024-06-12 03:44 AM | 139.0% |
| Wolfe Research | Andy Chen | $40 | $22.99 | 2024-06-10 03:16 PM | 74.0% |
| Evercore ISI | Liisa Bayko | $38 | $20.3 | 2024-05-15 04:06 AM | 87.2% |
| H.C. Wainwright | Ed Arce | $40 | $15.04 | 2023-10-11 11:35 AM | 166.0% |
| Evercore ISI | Liisa Bayko | $50 | $29.05 | 2022-09-13 04:03 PM | 72.1% |